This week's FierceBiotech is brought to you by CMIC Group.
Over 25 years ago, Dr. Nakamura founded CMIC as the first contract research organization (CRO) in Japan. Today, we are a full service provider with end to end solutions from preclinical to clinical, from development to manufacturing, from regulatory consulting to sales and marketing.
CMIC is the largest CRO in Japan today involved in near 80% of Japanâs new drug development and filing. We strive to be a Pharmaceutical Value Creator (PVC), spanning our services across the entire drug development value chain, and meeting customersâ needs in the U.S., Japan and broader Asia (China, Taiwan, Korea, Singapore, etc.)
Regulatory and operating environment changesFlexible conditions for clinical trialsScheduling clinical trials in JapanInvestigator, patient commitment to clinical trialsAnd much more
Want to reach 150,000+ FierceBiotech subscribers with your own message? Contact aalcover@fiercemarkets.com or call 202-824-5074.
About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech. Click here to unsubscribe. Refer to our Privacy Policy.
